Peter Bühlmayer

Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT₁‐receptor subtype

Leoluca Criscione, Marc de Gasparo, Peter Bühlmayer et al. · British Journal of Pharmacology · 1993 · 251 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Valsartan: Preclinical and Clinical Profile of an Antihypertensive Angiotensin‐II Antagonist

Leoluca Criscione, William A. Bradley, Peter Bühlmayer et al. · Cardiovascular Drug Reviews · 1995 · 132 citations

Medicine, Cardiology, Pharmacology +14

Pharmacokinetics, disposition and biotransformation of [14C]-radiolabelled valsartan in healthy male volunteers after a single oral dose

Felix Waldmeier, Gérard Flesch, P. Mu ̈ller et al. · Xenobiotica · 1997 · 131 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Valsartan, a potent, orally active angiotensin II antagonist developed from the structurally new amino acid series

Peter Bühlmayer, Pascual Furet, Leoluca Criscione et al. · Bioorganic & Medicinal Chemistry Letters · 1994 · 106 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Binding Characteristics and Vascular Effects of Various Angiotensin II Antagonists

Leoluca Criscione, H Thomann, Steven Whitebread et al. · Journal of Cardiovascular Pharmacology · 1990 · 60 citations

Medicine, Medicinal Chemistry, Pharmacology +12